Fig. 3From: Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplexCytotoxicity of LPPC-TAM in breast cancer cells. a MCF-7 (ER+), b BT474 (ER+), c MDA-MB-231 (ER−) and d human embryonic kidney HEK293 cells were treated with different concentrations LPPC, TAM or LPPC/TAM for 72 h. The cell viability was analyzed by MTT cytotoxicity (n = 6)Back to article page